柠檬酸亚铁钠改良颗粒与其它制剂的配伍性。

Y. Arai, T. Nakane, A. Kubota, N. Mizushima, T. Shibata
{"title":"柠檬酸亚铁钠改良颗粒与其它制剂的配伍性。","authors":"Y. Arai, T. Nakane, A. Kubota, N. Mizushima, T. Shibata","doi":"10.5649/jjphcs1975.25.176","DOIUrl":null,"url":null,"abstract":"Sodium Ferrous Citrate formulatio, Ferromia®granule was originally supplied as film-coated granules. However, some problems have been pointed out with this formulation regarding awkwardness in handling and unpleasantness during consumption.Therefore, corrigent was added while the film conting was removed in order to improve it.We investigated influence of changing the formilative method, and carry out the incompatibility test and hygroscopic test on 29 powders which can be admixed together. Furthermore, we also carried out a ferrous ion dissolution test on 11 powders which are likely to have an ionic interaction with iron. As a result, the modified granuls were incompatible when combined with ascorbic acid powder, Cinal ®granule, sodium bicarbonate and fblic acid powder (10%).The modified granules demonstrated no water-vapor sorption at 25°C, 75% RH at 30 days. Hygroscopicity was not considered to be related to incompatibility, and no noticeable difference was found due to the modification of the formulation.In the compounding the sample, dissolution property demonstrated only a slight difference in the ferrous ion elution.","PeriodicalId":14621,"journal":{"name":"Japanese Journal of Hospital Pharmacy","volume":"11 1","pages":"176-186"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Compatibility of Sodium Ferrous Citrate Improved-Granules in Combination with Other Preparations.\",\"authors\":\"Y. Arai, T. Nakane, A. Kubota, N. Mizushima, T. Shibata\",\"doi\":\"10.5649/jjphcs1975.25.176\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sodium Ferrous Citrate formulatio, Ferromia®granule was originally supplied as film-coated granules. However, some problems have been pointed out with this formulation regarding awkwardness in handling and unpleasantness during consumption.Therefore, corrigent was added while the film conting was removed in order to improve it.We investigated influence of changing the formilative method, and carry out the incompatibility test and hygroscopic test on 29 powders which can be admixed together. Furthermore, we also carried out a ferrous ion dissolution test on 11 powders which are likely to have an ionic interaction with iron. As a result, the modified granuls were incompatible when combined with ascorbic acid powder, Cinal ®granule, sodium bicarbonate and fblic acid powder (10%).The modified granules demonstrated no water-vapor sorption at 25°C, 75% RH at 30 days. Hygroscopicity was not considered to be related to incompatibility, and no noticeable difference was found due to the modification of the formulation.In the compounding the sample, dissolution property demonstrated only a slight difference in the ferrous ion elution.\",\"PeriodicalId\":14621,\"journal\":{\"name\":\"Japanese Journal of Hospital Pharmacy\",\"volume\":\"11 1\",\"pages\":\"176-186\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Hospital Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5649/jjphcs1975.25.176\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/jjphcs1975.25.176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

柠檬酸亚铁钠配方,铁®颗粒最初作为薄膜包覆颗粒供应。然而,这一配方也存在一些问题,如操作笨拙和消费过程中不愉快。因此,在去除含膜物的同时加入correct,以改善其性能。考察了不同制备方法对其的影响,并对可混合的29种粉末进行了不相容试验和吸湿试验。此外,我们还对11种可能与铁离子相互作用的粉末进行了亚铁离子溶解试验。结果表明,改性颗粒与抗坏血酸粉、Cinal®颗粒、碳酸氢钠和10%的硫酸粉配伍时不相容。改性颗粒在25°C, 75% RH条件下,30天无水蒸气吸附。吸湿性不被认为与不相容有关,并且由于配方的修改而没有发现明显的差异。在复合样品中,亚铁离子洗脱的溶解性能仅表现出轻微的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Compatibility of Sodium Ferrous Citrate Improved-Granules in Combination with Other Preparations.
Sodium Ferrous Citrate formulatio, Ferromia®granule was originally supplied as film-coated granules. However, some problems have been pointed out with this formulation regarding awkwardness in handling and unpleasantness during consumption.Therefore, corrigent was added while the film conting was removed in order to improve it.We investigated influence of changing the formilative method, and carry out the incompatibility test and hygroscopic test on 29 powders which can be admixed together. Furthermore, we also carried out a ferrous ion dissolution test on 11 powders which are likely to have an ionic interaction with iron. As a result, the modified granuls were incompatible when combined with ascorbic acid powder, Cinal ®granule, sodium bicarbonate and fblic acid powder (10%).The modified granules demonstrated no water-vapor sorption at 25°C, 75% RH at 30 days. Hygroscopicity was not considered to be related to incompatibility, and no noticeable difference was found due to the modification of the formulation.In the compounding the sample, dissolution property demonstrated only a slight difference in the ferrous ion elution.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment and Analysis of the Assessment Criteria for Meta-Analysis Articles:─ Management of Diabetes Pharmacotherapy Based on Meta-Analysis Articles ─ ベネコートBMI-40とBMI-60との苦味マスキング効果の比較 「創薬ボランティアのしおり」,「被験者管理票」の利用と治験コーディネーター業務 Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis An Investigation into the Current Management for Patients with Long-Term Withdrawal Periods from Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1